She was scheduled to undergo a radical vulvectomy on [**2102-11-15**], but it was abandoned when new palpable and visible lesions were seen on the rectovaginal septum.
Rectovaginal examination reveled a firm rectovaginal tumor, about 2 cm above the anus with ulceration through the posterior vaginal wall.
Pertinent Results: [**2102-12-13**] 08:41AM BLOOD WBC-15.2* RBC-4.00* Hgb-12.1 Hct-36.5 MCV-91 MCH-30.3 MCHC-33.2 RDW-14.3 Plt Ct-960* [**2102-12-3**] 03:13AM BLOOD WBC-18.6* RBC-2.56* Hgb-8.0* Hct-22.6* MCV-88 MCH-31.1 MCHC-35.3* RDW-13.3 Plt Ct-305 [**2102-12-15**] 06:35AM BLOOD PT-17.5* PTT-27.4 INR(PT)-1.9 [**2102-12-10**] 04:58AM BLOOD PT-35.4* PTT-45.4* INR(PT)-7.9 [**2102-12-11**] 05:29AM BLOOD Glucose-114* UreaN-6 Creat-0.6 Na-137 K-4.2 Cl-104 HCO3-29 AnGap-8 [**2102-12-12**] 05:47AM BLOOD Calcium-7.6* Phos-3.5 Mg-1.8 [**2102-12-14**] 08:42AM OTHER BODY FLUID Creat-0.4 JP Creatinine  Brief Hospital Course: On [**2102-11-30**] the patient underwent an exam under anesthesia, exploratory laparotomy, bilateral pelvic lymph node dissection, bilateral para-aortic lymph node dissection, total pelvic exenteration, radical vulvectomy, bilateral inguinal lymphadenectomy, sigmoid urinary conduit, omental transposition, transverse colostomy and bilateral gracilis myocutaneous graft.
Thereafter her HCT remained stable at 35.
By discharge, her INR was near therapeutic at 1.9.
Her electrolytes were repleted as needed, and by discharge, she was tolerating some solid foods.
She will need repeat debridement and possible regrafting as an outpatient.
Her abdominal JP drain had a creatine of 0.4 at discharge.
